EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants

Eva-Maria Sunzel, Giulia Ghibellini, Maria Gutierrez, Debra Ruffo, Shailendra Chavan, Nagnath G Birajdar, Frank Schneider, Pippa Loupe, Mark Forrest Gordon, Laura Rabinovich-Guilatt

Clinical Drug Investigation · 2026-08 · 46 (8) · 911-923

DOI: 10.1007/s40261-026-01566-8 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Drug Investigation, online erschienen am 19.06.2026. Verfasst von Eva-Maria Sunzel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA. Hauptthemen laut MEDLINE: Food-Drug Interactions, Tetrabenazine. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovative Medicines R&D Global Clinical Development Teva Pharmaceuticals Netanya Israel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food-Drug InteractionsTetrabenazineHumansCross-Over StudiesAdultFemaleMaleTabletsArea Under CurveDelayed-Action PreparationsMiddle AgedYoung AdultDose-Response Relationship, DrugAdolescentDrug Administration Schedule

Substanzen

TetrabenazinedeutetrabenazineTabletsDelayed-Action Preparations

Autor:innen und Institutionen

  • Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA.
  • Teva Clinics, Miramar, FL, USA.
  • Watson Pharma Pvt. Ltd. Seawoods, Navi-Mumbai, Maharashtra, India.
  • Teva Pharmaceutical Industries Ltd, Ratiopharm GmbH, Ulm, Germany.
  • Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, 145 Brandywine Parkway, West Chester, PA, 19380, USA. Pippa.Loupe@Tevapharm.com.
  • Innovative Medicines R&D Global Clinical Development, Teva Pharmaceuticals, Netanya, Israel.

Förderung

  • Innovative Medicines R&D Global Clinical Development Teva Pharmaceuticals Netanya Israel

Zitieren

APA

Sunzel, E. M., Ghibellini, G., Gutierrez, M., Ruffo, D., Chavan, S., Birajdar, N. G., Schneider, F., Loupe, P., Gordon, M. F., & Rabinovich-Guilatt, L. (2026). Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants. Clinical Drug Investigation, 46(8), 911-923. https://doi.org/10.1007/s40261-026-01566-8

Vancouver

Sunzel EM, Ghibellini G, Gutierrez M, Ruffo D, Chavan S, Birajdar NG, et al. Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants. Clinical Drug Investigation. 2026;46(8):911-923. doi:10.1007/s40261-026-01566-8

BibTeX
@article{Sunzel2026,
  author = {Sunzel, Eva-Maria and Ghibellini, Giulia and Gutierrez, Maria and Ruffo, Debra and Chavan, Shailendra and Birajdar, Nagnath G and Schneider, Frank and Loupe, Pippa and Gordon, Mark Forrest and Rabinovich-Guilatt, Laura},
  title = {Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants},
  journal = {Clinical Drug Investigation},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {911--923},
  doi = {10.1007/s40261-026-01566-8}
}
Kostenlos starten →